Comparing pneumonia risk in COPD patients initiating Fixed Dose Combination (FDC) inhaler comprising extrafine beclometasone dipropionate versus fluticasone
Date
2021-09-05
Journal Title
Journal ISSN
Volume Title
Publisher
Citation
Price, D, Henley, W, Carter, V, Skinner, D, Vella, R, Papi, A, Fabbri, L M, Kerstjens, H AM, Roche, N, Singh, D, Vogelmeier, C F, Şen, E, Delfini Cançado, J E, Nudo, E, Barile, S & Georges, G 2021, 'Comparing pneumonia risk in COPD patients initiating Fixed Dose Combination (FDC) inhaler comprising extrafine beclometasone dipropionate versus fluticasone', European Respiratory Journal, vol. 58, no. Suppl. 65, OA2952. https://doi.org/10.1183/13993003.congress-2021.OA2952